Accelerate diagnostics presents new data at eccmid 2022 demonstrating rapid and accurate results using automated accelerate arc™ module and bc kit

New data shows the accelerate arc system enables automated and rapid sample preparation that yields robust reportability and accurate microbial identification for positive blood cultures using maldi when compared to conventional maldi methods tucson, ariz. , april 25, 2022 /prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the release of new data on the accelerate arc module and bc kit at the 32nd european congress for clinical microbiology and infectious diseases (eccmid) located in lisbon, portugal 23-26 april 2022.
AXDX Ratings Summary
AXDX Quant Ranking